GGrantIndex
← Leaderboards

Ryan A Altman

Purdue University

$5,524,866
Attributed
$5,930,252
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $933.5K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,930,252 · 8

By mechanism

R35$3,667,403 · 1
R21$1,183,898 · 3
R33$706,000 · 1
P20$206,719 · 1
F32$127,493 · 1
F31$38,739 · 1

Top collaborators

Most similar at Purdue University

Same institution · by research overlap

Others in their field

Top investigators on “In Vitro

Research focus

In VitroPharmaceutical PreparationsIn VivoReactionBiologicalPharmaceutical ChemistryMethodologyLigandsPropertyAnalogDesignDrug KineticsInnovationAlkenesTherapeutic CandidateAlcoholsProteinsBiophysicsNovel TherapeuticsCatalystFunctional GroupPreparationAffectBase

Grant awards (26)

Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry$407,911
R35 · FY2025 · GM · contact PI
Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry$407,911
R35 · FY2024 · GM · contact PI
Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry$68,050
R35 · FY2024 · GM · contact PI
Grant Supplement to Support Diversity in Health-Related Research$22,685
R35 · FY2024 · GM · contact PI
Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry$407,911
R35 · FY2023 · GM · contact PI
Identification of CNS-Penetrant Tryptophan 2,3-Dioxygenase Degrading Ligands$184,651
R21 · FY2023 · AG · contact PI
Targeting Tryptophan Dioxygenase Degradation for Suppression of Tumor Immune Evasion$169,589
R21 · FY2023 · CA · contact PI
Chromatography System for Organic Synthesis-Administrative Supplements for Equipment Purchases$87,227
R35 · FY2023 · GM · contact PI
Fluorination and Fluoroalkylation Strategies for Synthetic and Medicinal Chemistry$407,911
R35 · FY2022 · GM · contact PI
Identification of CNS-Penetrant Tryptophan 2,3-Dioxygenase Degrading Ligands$235,901
R21 · FY2022 · AG · contact PI
Targeting Tryptophan Dioxygenase Degradation for Suppression of Tumor Immune Evasion$220,632
R21 · FY2022 · CA · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$375,488
R35 · FY2021 · GM · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$375,488
R35 · FY2020 · GM · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$282,357
R35 · FY2019 · GM · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$86,916
R35 · FY2019 · GM · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$368,617
R35 · FY2018 · GM · contact PI
Evaluation of Physicochemical Properties Imparted by Fluorinated Peptidomimetics$358,150
R33 · FY2018 · DA · contact PI
Project 1: Resistance Modifying Agents for Aminoglycoside Antibiotics$206,719
P20 · FY2018 · GM · contact PI
Fluoroalkylethers and Fluorinated Ethermimetics$368,931
R35 · FY2017 · GM · contact PI
Evaluation of Physicochemical Properties Imparted by Fluorinated Peptidomimetics$347,850
R33 · FY2017 · DA · contact PI
Evaluation of Physicochemical Properties Imparted by Fluorinated Peptidomimetics$185,625
R21 · FY2016 · DA · contact PI
Evaluation of Physicochemical Properties Imparted by Fluorinated Peptidomimetics$187,500
R21 · FY2015 · DA · contact PI
Asymmetric Pd(II)-catalyzed Ring-forming Reactions$35,437
F32 · FY2010 · GM · contact PI
Asymmetric Pd(II)-catalyzed Ring-forming Reactions$47,210
F32 · FY2009 · GM · contact PI
Asymmetric Pd(II)-catalyzed Ring-forming Reactions$44,846
F32 · FY2008 · GM · contact PI
CU-Catalyzed C(aryl)-N and C(aryl)-O Bond-forming Reactions$38,739
F31 · FY2007 · GM · contact PI